Open AccessPerformance of Disease-Specific Scoring Models in Intensive Care Patients with Severe Liver Diseases
Author(s) -
El-Ghannam Mt,
Hassanien Mh,
El-Talkawy,
Saleem Aaa,
Sabry Ai,
Abu Taleb Hm
Publication year - 2017
Publication title -
journal of clinical and diagnostic research
Language(s) - English
Resource type - Journals
eISSN - 2249-782X
pISSN - 0973-709X
DOI - 10.7860/jcdr/2017/24543.9980
Subject(s) - medicine , liver disease , hepatic encephalopathy , model for end stage liver disease , prioritization , disease , encephalopathy , intensive care unit , hepatitis a virus , intensive care medicine , cirrhosis , liver transplantation , virus , management science , virology , transplantation , economics
Egypt has the highest prevalence of Hepatitis C Virus (HCV) in the world, estimated nationally at 14.7%. HCV treatment consumes 20% ($80 million) of Egypt's annual health budget. Outcomes of cirrhotic patients admitted to the ICU may, in fact, largely depend on differences in the state of the disease, criteria and indications for admission, resource utilization, and intensity of treatment.